LYNDLEY CORLEY: Open Payments
NPI 1871224147 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 19 payments from 9 companies in 2025. Trend: 2023 $738 · 2024 $810 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $229 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $109 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| Alkermes, Inc. | 1 | $104 |
| Janssen Pharmaceuticals, Inc | 1 | $87 |
| E.R. Squibb & Sons, L.L.C. | 1 | $82 |
Products named: VRAYLAR, CAPLYTA, Qelbree, UZEDY, REXULTI, Auvelity, ARISTADA, INVEGA.
Industry payments across OH — which companies pay providers there.
